Seelos Therapeutics Inc
NASDAQ:SEEL

Watchlist Manager
Seelos Therapeutics Inc Logo
Seelos Therapeutics Inc
NASDAQ:SEEL
Watchlist
Price: 2.34 USD 706.34% Market Closed
Updated: May 17, 2024

Seelos Therapeutics Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Seelos Therapeutics Inc
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Seelos Therapeutics Inc
NASDAQ:SEEL
Cash from Operating Activities
-$23.9m
CAGR 3-Years
-5%
CAGR 5-Years
-72%
CAGR 10-Years
-5%
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$23.2B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$13.7B
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8.7B
CAGR 3-Years
-18%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$14.8B
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$3.7B
CAGR 3-Years
-22%
CAGR 5-Years
-7%
CAGR 10-Years
-4%

See Also

What is Seelos Therapeutics Inc's Cash from Operating Activities?
Cash from Operating Activities
-23.9m USD

Based on the financial report for Dec 31, 2023, Seelos Therapeutics Inc's Cash from Operating Activities amounts to -23.9m USD.

What is Seelos Therapeutics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-5%

Over the last year, the Cash from Operating Activities growth was 61%. The average annual Cash from Operating Activities growth rates for Seelos Therapeutics Inc have been -5% over the past three years , -72% over the past five years , and -5% over the past ten years .